Bio Essence Corporation
BIOE
$0.18
-$0.07-27.96%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 179.30% | 168.47% | 89.12% | -132.59% | -150.13% |
| Total Depreciation and Amortization | -50.00% | -66.67% | 102.04% | 104.55% | -70.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.63% | -96.23% | -95.65% | 15,062.35% | 8,204.09% |
| Change in Net Operating Assets | -115.18% | -22.87% | 152.17% | 1,193.69% | 452.82% |
| Cash from Operations | 53.87% | 151.61% | 22,881.82% | 230.73% | 179.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 99.89% | 99.89% | 99.89% |
| Total Debt Issued | 448.74% | -- | -48.11% | -71.62% | -86.55% |
| Total Debt Repaid | -163.85% | -281.70% | -150.28% | -2,833.10% | -8,542.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 100.00% |
| Cash from Financing | -49.17% | -152.39% | -722.15% | -215.59% | -172.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18,200.00% | -216.67% | -104.35% | -206.59% | -- |